[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100630475":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":20,"locations":21,"responsibleParty":43,"collaborators":45,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":20,"eligibilityCriteria":55,"healthyVolunteers":51,"sex":56,"minAge":57,"maxAge":58,"enrollmentInfo":59,"targetDuration":20,"studyType":62,"phases":63,"briefSummary":65,"conditions":66,"keywords":70,"overallStatus":75,"whyStopped":20,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Louisiana State University Health Sciences Center in New Orleans","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients admitted to the inpatient psychiatric unit with a schizophrenia spectrum disorder diagnosis","EXPERIMENTAL","Patients will be exposed to educational materials in the form of a pamphlet and a video",[13],"Behavioral: Educational sessions",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"BEHAVIORAL","Educational sessions","Patients will be given an educational pamphlet with information about schizophrenia spectrum disorders, including prognosis and management options. Following this, they will be allowed to ask the doctor any questions they have pertaining to schizophrenia spectrum disorder. In the second educational session, patients will watch a video containing information about schizophrenia spectrum disorders. Following this, they will be allowed to ask the doctor any questions they have pertaining to this topic.",[9],null,[22],{"facility":23,"status":20,"city":24,"state":25,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"University Medical Center","New Orleans","Louisiana","70112","United States","US",{"type":30,"coordinates":31},"Point",[32,33],-90.07507,29.95465,{"lat":33,"lon":32},[36,41],{"name":37,"role":38,"phone":39,"phoneExt":20,"email":40},"Jaudé Petrie, MD","CONTACT","504-702-3000","jpetri@lsuhsc.edu",{"name":37,"role":42,"phone":20,"phoneExt":20,"email":20},"PRINCIPAL_INVESTIGATOR",{"type":44,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR",[46],{"name":47,"class":48},"Janssen Pharmaceuticals","INDUSTRY","100630475","improving-health-literacy-in-patients-with-schizophrenia-spectrum-disorder-100630475",false,"NCT07488156","Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder","The Impact of Health Literacy on the Attitudes Toward Pharmacological Treatment in Patients With Schizophrenia Spectrum Disorder","Inclusion Criteria:\n\n* Patients admitted to the University Medical Center-New Orleans (UMCNO) inpatient behavioral health unit ages 18 and older with a new or previous diagnosis of schizophrenia spectrum disorder outside of substance use disorders\n* Patients must be proficient in English.\n* Patients must have a government issued social security number (required for reimbursement through the university).\n\nExclusion Criteria:\n\n* Patients at UMCNO that are ages 17 or younger\n* Patients with SSD and concomitant intellectual disability, as evidenced by prior documented history on chart review or patients suspected to have intellectual disability or impairment based on clinical interactions\n* Patients with concomitant substance use and documentation of psychosis being resolved after a period of washout and without the use of psychotropic medications\n* Patients unable to complete health literacy assessments, attitude towards treatment assessments, and IQ testing due to severity of symptoms during hospitalization\n* Patients that are not proficient in English\n* Patients that do not have a government issued social security number","ALL","18 Years","65 Years",{"count":60,"type":61},34,"ESTIMATED","INTERVENTIONAL",[64],"NA","The Impact of Health Literacy on the Attitudes toward Pharmacological Treatment in Patients with Schizophrenia Spectrum Disorder\n\nThis interventional study is aimed at:\n\n* assessing and improving the health literacy and\n* assessing the attitude towards treatment of patients with schizophrenia spectrum disorders while they are admitted to the inpatient psychiatric unit.",[67,68,69],"Schizophrenia Disorder","Schizoaffective Disorder","Psychosis",[71,72,73,74],"Educational interventions","Schizophrenia","Schizophrenia spectrum disorders","Health literacy","NOT_YET_RECRUITING","2026-03-17",{"date":78,"type":79},"2026-03-23","ACTUAL",{"date":81,"type":61},"2026-03-01",{"date":83,"type":61},"2028-01-01",{"name":5,"class":6},1]